|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Cash flows from operating activities | ||
| Net income | ||
| Adjustments to reconcile net income to net cash provided by operating activities | ||
| Depreciation and amortization | ||
| Amortization and write-off of deferred financing fees | ||
| Stock-based compensation | ||
| Loss on investment in partnership | ||
| Gain on insurance subsidiary deposits and investments | ||
| Deferred taxes | ||
| Noncash lease expense | ||
| Other noncash operating activities | ||
| Change in operating assets and liabilities | ||
| Accounts receivable, net | ||
| Other receivables | ||
| Prepaid expenses and other current assets | ||
| Other assets | ||
| Escrow funds | ||
| Operating lease liabilities | ||
| Accounts payable | ||
| Accrued payroll and benefits | ||
| Accrued self-insurance liabilities | ||
| Refund liability | ||
| Other accrued expenses | ||
| Other liabilities | ||
| NET CASH PROVIDED BY OPERATING ACTIVITIES | ||
| Cash flows from investing activities | ||
| Investment in partnerships | ||
| Non-operating distributions from investment in partnership | ||
| Purchase of available-for-sale securities | ||
| Sale of available-for-sale securities | ||
| Acquisition of facilities | ||
| Purchase of property and equipment | ||
| Proceeds from the sale of assets | ||
| NET CASH USED IN INVESTING ACTIVITIES | ||
| Cash flows from financing activities | ||
| Borrowing on lines of credit, net of deferred financing fees | ||
| Payments on lines of credit | ||
| Borrowings of long-term debt, net of deferred financing fees | ||
| Payments on long-term debt | ||
| Noncontrolling interest distribution | ||
| Contributions from noncontrolling interest | ||
| Dividends on common stock | ||
| Proceeds from initial public offering, net of issuance costs | ||
| Proceeds from common stock offering, net of issuance costs | ||
| Taxes paid related to net share settlement of equity awards | ||
| NET CASH (USED IN)/PROVIDED BY FINANCING ACTIVITIES | ||
| Net change in cash | ||
| Cash, cash equivalents, and restricted cash - beginning of period | ||
| Cash, cash equivalents, and restricted cash - end of period | ||
| Supplemental disclosures of cash flow information | ||
| Interest | ||
| Income taxes | ||
| Non-cash financing and investing activity | ||
| Accrued capital expenditures | ||
| Assets acquired in operation expansions in exchange for notes payable | ||
| Assets acquired in operation expansions through settlement of notes receivable | ||
| Contributions from noncontrolling interest through relief of notes payable | ||
| Cash and cash equivalents | ||
| Restricted cash | ||
| Prepaid Expenses and Other Current Assets | ||
| Other Assets |
Loading...
